Patent · US Active

Preparation of low bleeding anticoagulant fusion protein and its use

US8101379B2 · kind B2 · utility

1Cited by

2References

9Claims

0Family size

Assignees

Institute of radiation medicine, academy of military medical sciences, PLA. · CN
Beijing Sanly Sci-Tech Develop Inc. Ltd. · CN

Inventors

Zuze Wu · Beijing, CN
Aiping Yu · Beijing, CN
Chuanling Zhang · Beijing, CN
Zhongxiong Tang · Beijing, CN

Key dates

Filing date	Dec 11, 2007
Grant date	Jan 24, 2012
Priority date	—
Expiry date	Dec 11, 2027

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07K2319/00
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Provided is an anticoagulant fusion protein comprising oligopeptide recognizable and cleavable by either factor XIa and factor Xa or thrombin and factor Xa. Also provided are the preparation method of the anticoagulant fusion protein and medicinal use thereof.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.